Aurobindo Pharma gets USFDA warning letter for Andhra Pradesh unit Farhat Nasim21 Jun 2019 12:29 PM ISTThe company has received a warning letter from the United States Food and Drug Administration (USFDA) relating to our unit XI, active pharmaceutical...
Sanofi to slash 466 jobs as part of R&D restructure Farhat Nasim21 Jun 2019 10:47 AM ISTThe 466 job cuts are to be implemented on a voluntary basis, Sanofi said. The company currently employs 15,000 in R&D worldwide out of total...
Piramal Pharma invests over Rs 69 crore to expand its API capability Medical Dialogues Bureau21 Jun 2019 10:00 AM ISTThe new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions...
Bayer Stivarga becomes first drug to be tested in brain cancer patients in multi-arm cooperation trial Farhat Nasim21 Jun 2019 9:15 AM ISTBayer's Stivarga will be the first drug to be evaluated in this trial.New Delhi: Bayer announced today that the Stivarga (regorafenib) arm of the...
Merck CEO sees legal challenge if US adopts drug pricing based on other countries Medical Dialogues Bureau21 Jun 2019 9:00 AM ISTEarlier on Thursday, Merck executives touted the company's pipeline of experimental drugs beyond its blockbuster cancer treatment Keytruda.NEW YORK:...
Alleged Pharma Influence : World Health Organisation calls for Discontinuation of two Publications Medical Dialogues Bureau20 Jun 2019 1:37 PM ISTThe World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in...
Glenmark Pharma gets tentative nod from USFDA for acne treatment drug Medical Dialogues Bureau20 Jun 2019 1:33 PM ISTNew Delhi: Glenmark Pharmaceuticals Thursday it has received tentative approval from the US health regulator for Clindamycin Phosphate Foam, used to...
Indian Pharma aspiring to grow to 120-130 billion Dollar Industry by 2030: IPA Medical Dialogues Bureau20 Jun 2019 1:29 PM ISTNEW DELHI: The Indian pharmaceutical industry is aspiring to touch USD 120-130 billion by 2030 from the current USD 38 billion, industry body Indian...
AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment Medical Dialogues Bureau19 Jun 2019 12:02 PM ISTBritish drugmaker AstraZeneca Plc on Tuesday said its cancer medicine Lynparza was approved as a first-line maintenance treatment for a type of...
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTAHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
Roche wins Japan approval for personalised cancer drug Rozlytrek Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTOnline pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan,...
